keyLogo

Johan Wikstrom

Hi, I'm Johan Wikstrom - CEO, Cofounder at Tolka AI Therapeutics

I am deeply driven by the potential of precision medicine to solve medical mysteries that seem impossible. I thrive in high-stakes environments where computational logic meets real-world clinical patient care.

Tolka AI Therapeutics
Miami, FL, USA
AI insights

At a glance

Curated signals on strengths, focus areas, and how they can help.

Developed foundational software engineering expertise while working at Google and leading technical teams at high-growth startups.

Leads a high-impact biotech venture focused on deploying personalized phage therapy through FDA-approved expanded access pathways.

Provides strategic guidance on navigating regulatory hurdles and securing venture backing for complex medical technology startups.

🚀 Career trajectory

Engineering Foundations

Built robust software systems at Google and high-growth startups, mastering large-scale data and algorithm development.

Software Engineering

Machine Learning

Biotech Transformation

Pivoted into personalized medicine, leveraging computational background to address critical gaps in infection control.

Founder Experience

Clinical Operations

💪🏻 Superpowers

Clinical Innovation Architect

Designing patient-tailored medical pathways under regulatory rigor

Navigated complex FDA and IRB frameworks for expanded access therapy.

Scaled personalized medicine models for hard-to-treat bacterial infections.

Synthesized biotech research into actionable, patient-facing treatment solutions.

Systems Thinking Catalyst

Applying machine learning paradigms to solve biological bottlenecks

Leveraged software engineering expertise to optimize therapeutic drug discovery.

Standardized small-batch manufacturing protocols for phage therapy deployment.

Automated logic-based diagnostic workflows to improve patient outcomes.

Venture-Backed Leadership

Securing cross-sector backing to scale high-risk medical solutions

Secured foundational support from top-tier VCs like Khosla and Draper.

Aligned institutional research goals with rapid private sector execution.

Communicated high-stakes medical vision to diverse investor and clinical stakeholders.

I'm excited about

Exploring strategic partnerships with fellow biotech founders to refine clinical delivery models.

Connecting with peers in personalized medicine to discuss future regulatory trends in therapy.

Seeking collaborative environments to pressure-test scalable models for rare infectious disease treatment.

I can help with

Advising founders on transitioning technical engineering skills into regulated medical hardware or biotech sectors.

Sharing insights on navigating the FDA expanded access path for complex patient-tailored therapeutics.

Mentoring on pitching hard-science innovations to venture capital firms focused on long-term healthcare impacts.

I would love your help on

Connecting with experts in clinical immunology to pressure-test our expanded access patient outreach program.

Gaining feedback from seasoned healthcare operators on scaling patient-centric therapeutic manufacturing in restricted markets.

Seeking advisors with deep experience in public-private partnerships to bridge institutional and commercial research gaps.